The Biotech Growth Trust (BIOG) Competitors

GBX 1,288 +28.00 (+2.22%)

As of 12:04 PM Eastern

BIOG vs. SDP, GROW, EDIN, TRY, and JPE

Should you buy The Biotech Growth Trust stock or one of its competitors? MarketBeat compares The Biotech Growth Trust with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with The Biotech Growth Trust include Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), Molten Ventures (GROW), Edinburgh Investment (EDIN), TR Property Investment Trust (TRY), and JPMorgan Elect plc - Managed Growth (JPE). These companies are all part of the "asset management" industry.

How does The Biotech Growth Trust compare to Schroder Investment Trust - Schroder AsiaPacific Fund?

The Biotech Growth Trust (LON:BIOG) and Schroder Investment Trust - Schroder AsiaPacific Fund (LON:SDP) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

5.5% of The Biotech Growth Trust shares are owned by institutional investors. Comparatively, 17.2% of Schroder Investment Trust - Schroder AsiaPacific Fund shares are owned by institutional investors. 2.7% of The Biotech Growth Trust shares are owned by insiders. Comparatively, 0.2% of Schroder Investment Trust - Schroder AsiaPacific Fund shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Schroder Investment Trust - Schroder AsiaPacific Fund has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Schroder Investment Trust - Schroder AsiaPacific Fund, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Biotech Growth Trust	-£17.73M	-14.24	£83.83M	-£14.30	N/A
Schroder Investment Trust - Schroder AsiaPacific Fund	£127.21M	8.01	£121.21M	£87.16	9.20

The Biotech Growth Trust has a beta of 0.59097034, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Schroder Investment Trust - Schroder AsiaPacific Fund has a beta of 1.023251, suggesting that its share price is 2% more volatile than the broader market.

The Biotech Growth Trust has a net margin of 140.73% compared to Schroder Investment Trust - Schroder AsiaPacific Fund's net margin of 90.43%. Schroder Investment Trust - Schroder AsiaPacific Fund's return on equity of 13.69% beat The Biotech Growth Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Biotech Growth Trust	140.73%	-8.91%	12.39%
Schroder Investment Trust - Schroder AsiaPacific Fund	90.43%	13.69%	-1.73%

In the previous week, The Biotech Growth Trust had 1 more articles in the media than Schroder Investment Trust - Schroder AsiaPacific Fund. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for Schroder Investment Trust - Schroder AsiaPacific Fund. The Biotech Growth Trust's average media sentiment score of 1.42 beat Schroder Investment Trust - Schroder AsiaPacific Fund's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.

Company	Overall Sentiment
The Biotech Growth Trust	Positive
Schroder Investment Trust - Schroder AsiaPacific Fund	Neutral

Summary

Schroder Investment Trust - Schroder AsiaPacific Fund beats The Biotech Growth Trust on 8 of the 13 factors compared between the two stocks.

How does The Biotech Growth Trust compare to Molten Ventures?

Molten Ventures (LON:GROW) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Molten Ventures currently has a consensus price target of GBX 599.67, indicating a potential upside of 2.07%. Given Molten Ventures' stronger consensus rating and higher probable upside, analysts plainly believe Molten Ventures is more favorable than The Biotech Growth Trust.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molten Ventures	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
The Biotech Growth Trust	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

The Biotech Growth Trust has lower revenue, but higher earnings than Molten Ventures. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Molten Ventures, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molten Ventures	£125.60M	8.06	-£33.58M	£61.60	9.54
The Biotech Growth Trust	-£17.73M	-14.24	£83.83M	-£14.30	N/A

Molten Ventures has a beta of 1.265, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, The Biotech Growth Trust has a beta of 0.59097034, suggesting that its stock price is 41% less volatile than the broader market.

Molten Ventures has a net margin of 193.06% compared to The Biotech Growth Trust's net margin of 140.73%. Molten Ventures' return on equity of 8.81% beat The Biotech Growth Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molten Ventures	193.06%	8.81%	-3.46%
The Biotech Growth Trust	140.73%	-8.91%	12.39%

In the previous week, Molten Ventures and Molten Ventures both had 1 articles in the media. The Biotech Growth Trust's average media sentiment score of 1.42 beat Molten Ventures' score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molten Ventures	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
The Biotech Growth Trust	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

41.3% of Molten Ventures shares are held by institutional investors. Comparatively, 5.5% of The Biotech Growth Trust shares are held by institutional investors. 1.6% of Molten Ventures shares are held by company insiders. Comparatively, 2.7% of The Biotech Growth Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Molten Ventures beats The Biotech Growth Trust on 11 of the 15 factors compared between the two stocks.

How does The Biotech Growth Trust compare to Edinburgh Investment?

Edinburgh Investment (LON:EDIN) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

8.4% of Edinburgh Investment shares are held by institutional investors. Comparatively, 5.5% of The Biotech Growth Trust shares are held by institutional investors. 0.3% of Edinburgh Investment shares are held by company insiders. Comparatively, 2.7% of The Biotech Growth Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Edinburgh Investment has a beta of 0.9612611, suggesting that its stock price is 4% less volatile than the broader market. Comparatively, The Biotech Growth Trust has a beta of 0.59097034, suggesting that its stock price is 41% less volatile than the broader market.

In the previous week, Edinburgh Investment had 4 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 5 mentions for Edinburgh Investment and 1 mentions for The Biotech Growth Trust. The Biotech Growth Trust's average media sentiment score of 1.42 beat Edinburgh Investment's score of 1.40 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edinburgh Investment	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
The Biotech Growth Trust	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

The Biotech Growth Trust has a net margin of 140.73% compared to Edinburgh Investment's net margin of 90.04%. Edinburgh Investment's return on equity of 7.06% beat The Biotech Growth Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edinburgh Investment	90.04%	7.06%	6.69%
The Biotech Growth Trust	140.73%	-8.91%	12.39%

Edinburgh Investment has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Edinburgh Investment, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edinburgh Investment	£82.18M	12.53	£180.50M	£57.48	13.80
The Biotech Growth Trust	-£17.73M	-14.24	£83.83M	-£14.30	N/A

Summary

Edinburgh Investment beats The Biotech Growth Trust on 9 of the 13 factors compared between the two stocks.

How does The Biotech Growth Trust compare to TR Property Investment Trust?

The Biotech Growth Trust (LON:BIOG) and TR Property Investment Trust (LON:TRY) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

In the previous week, The Biotech Growth Trust had 1 more articles in the media than TR Property Investment Trust. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for TR Property Investment Trust. The Biotech Growth Trust's average media sentiment score of 1.42 beat TR Property Investment Trust's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.

Company	Overall Sentiment
The Biotech Growth Trust	Positive
TR Property Investment Trust	Neutral

TR Property Investment Trust has a net margin of 180.40% compared to The Biotech Growth Trust's net margin of 140.73%. TR Property Investment Trust's return on equity of -3.35% beat The Biotech Growth Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Biotech Growth Trust	140.73%	-8.91%	12.39%
TR Property Investment Trust	180.40%	-3.35%	-24.58%

The Biotech Growth Trust has a beta of 0.59097034, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, TR Property Investment Trust has a beta of 1.4909836, suggesting that its stock price is 49% more volatile than the broader market.

TR Property Investment Trust has lower revenue, but higher earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than TR Property Investment Trust, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Biotech Growth Trust	-£17.73M	-14.24	£83.83M	-£14.30	N/A
TR Property Investment Trust	-£27.26M	-36.85	£284.71M	-£11.35	N/A

5.5% of The Biotech Growth Trust shares are owned by institutional investors. Comparatively, 12.6% of TR Property Investment Trust shares are owned by institutional investors. 2.7% of The Biotech Growth Trust shares are owned by company insiders. Comparatively, 0.2% of TR Property Investment Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

TR Property Investment Trust beats The Biotech Growth Trust on 7 of the 13 factors compared between the two stocks.

How does The Biotech Growth Trust compare to JPMorgan Elect plc - Managed Growth?

JPMorgan Elect plc - Managed Growth (LON:JPE) and The Biotech Growth Trust (LON:BIOG) are both small-cap asset management industry companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

The Biotech Growth Trust has lower revenue, but higher earnings than JPMorgan Elect plc - Managed Growth. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than JPMorgan Elect plc - Managed Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
JPMorgan Elect plc - Managed Growth	£104.78M	0.00	N/A	£0.75	N/A
The Biotech Growth Trust	-£17.73M	-14.24	£83.83M	-£14.30	N/A

In the previous week, The Biotech Growth Trust had 1 more articles in the media than JPMorgan Elect plc - Managed Growth. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for JPMorgan Elect plc - Managed Growth. The Biotech Growth Trust's average media sentiment score of 1.42 beat JPMorgan Elect plc - Managed Growth's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.

Company	Overall Sentiment
JPMorgan Elect plc - Managed Growth	Neutral
The Biotech Growth Trust	Positive

The Biotech Growth Trust has a net margin of 140.73% compared to JPMorgan Elect plc - Managed Growth's net margin of 0.00%. JPMorgan Elect plc - Managed Growth's return on equity of 0.00% beat The Biotech Growth Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
JPMorgan Elect plc - Managed Growth	N/A	N/A	N/A
The Biotech Growth Trust	140.73%	-8.91%	12.39%

5.5% of The Biotech Growth Trust shares are held by institutional investors. 2.7% of The Biotech Growth Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

The Biotech Growth Trust beats JPMorgan Elect plc - Managed Growth on 6 of the 10 factors compared between the two stocks.

Get The Biotech Growth Trust News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BIOG vs. The Competition

Export

Metric	The Biotech Growth Trust	Asset Management Industry	Financial Sector	LON Exchange
Market Cap	£252.46M	£2.36B	£5.83B	£2.80B
Dividend Yield	N/A	5.97%	5.25%	6.16%
P/E Ratio	-90.07	25.25	15.87	365.58
Price / Sales	-14.24	1,999.45	1,258.26	87,559.45
Price / Cash	87.74	60.17	91.78	27.89
Price / Book	1.20	1.36	6.58	7.61
Net Income	£83.83M	£265.53M	£1.15B	£5.89B
7 Day Performance	-4.73%	-0.34%	-0.01%	-0.11%
1 Month Performance	-3.30%	1.48%	1.27%	0.98%
1 Year Performance	75.00%	12.32%	19.02%	85.03%

The Biotech Growth Trust Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BIOG The Biotech Growth Trust	N/A	GBX 1,288 +2.2%	N/A	+73.6%	£252.46M	-£17.73M	N/A	N/A	Positive News
SDP Schroder Investment Trust - Schroder AsiaPacific Fund	N/A	GBX 807.07 +0.3%	N/A	+49.7%	£1.03B	£127.21M	9.26	N/A	Positive News
GROW Molten Ventures	0.8026 of 5 stars	GBX 593.63 +1.2%	GBX 599.67 +1.0%	+87.2%	£1.02B	£125.60M	9.64	20
EDIN Edinburgh Investment	N/A	GBX 780.03 -1.0%	N/A	-1.8%	£1.01B	£82.18M	13.57	N/A	Positive News Earnings Report
TRY TR Property Investment Trust	N/A	GBX 317 -0.8%	N/A	-2.3%	£1.01B	-£27.26M	N/A	26	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:BIOG) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Biotech Growth Trust (BIOG) Competitors

BIOG vs. SDP, GROW, EDIN, TRY, and JPE

How does The Biotech Growth Trust compare to Schroder Investment Trust - Schroder AsiaPacific Fund?

Summary

How does The Biotech Growth Trust compare to Molten Ventures?

Summary

How does The Biotech Growth Trust compare to Edinburgh Investment?

Summary

How does The Biotech Growth Trust compare to TR Property Investment Trust?

Summary

How does The Biotech Growth Trust compare to JPMorgan Elect plc - Managed Growth?

Summary

Media Sentiment Over Time

BIOG vs. The Competition

The Biotech Growth Trust Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

The Biotech Growth Trust (BIOG) Competitors

BIOG vs. SDP, GROW, EDIN, TRY, and JPE

How does The Biotech Growth Trust compare to Schroder Investment Trust - Schroder AsiaPacific Fund?

Do institutionals and insiders have more ownership in BIOG or SDP?

Which has better earnings & valuation, BIOG or SDP?

Which has more volatility and risk, BIOG or SDP?

Is BIOG or SDP more profitable?

Does the media favor BIOG or SDP?

Summary

How does The Biotech Growth Trust compare to Molten Ventures?

Do analysts recommend GROW or BIOG?

Which has stronger valuation & earnings, GROW or BIOG?

Which has more risk and volatility, GROW or BIOG?

Is GROW or BIOG more profitable?

Does the media favor GROW or BIOG?

Do insiders & institutionals believe in GROW or BIOG?

Summary

How does The Biotech Growth Trust compare to Edinburgh Investment?

Do institutionals and insiders have more ownership in EDIN or BIOG?

Which has more volatility and risk, EDIN or BIOG?

Does the media prefer EDIN or BIOG?

Is EDIN or BIOG more profitable?

Which has preferable valuation and earnings, EDIN or BIOG?

Summary

How does The Biotech Growth Trust compare to TR Property Investment Trust?

Does the media favor BIOG or TRY?

Is BIOG or TRY more profitable?

Which has more volatility & risk, BIOG or TRY?

Which has higher valuation & earnings, BIOG or TRY?

Do insiders and institutionals believe in BIOG or TRY?

Summary

How does The Biotech Growth Trust compare to JPMorgan Elect plc ­- Managed Growth?

Which has higher valuation and earnings, JPE or BIOG?

Does the media favor JPE or BIOG?

Is JPE or BIOG more profitable?

Do institutionals and insiders hold more shares of JPE or BIOG?

Summary

Media Sentiment Over Time

BIOG vs. The Competition

The Biotech Growth Trust Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

How does The Biotech Growth Trust compare to JPMorgan Elect plc - Managed Growth?